Deruxtecan
CAS: 1599440-13-7
Ref. 3D-ZNC44013
| 1mg | A consultar | ||
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 500µg | A consultar |
Información del producto
Deruxtecan is a monoclonal antibody that binds to epidermal growth factor (EGF) receptors, which are present on the surface of cancer cells and on other cells of the body. It induces apoptosis by activating the EGFR-related receptor tyrosine kinase and blocking downstream signaling pathways. Deruxtecan has been shown to inhibit tumor growth in xenograft models in mice. The drug also has potent antitumor activity against solid tumors, such as breast cancer. Deruxtecan is a pyrimidine compound that interacts with toll-like receptor 4 (TLR4). This interaction results in TLR4 activation and subsequent dendritic cell activation and release of cytokines.
Propiedades químicas
Consulta técnica sobre: 3D-ZNC44013 Deruxtecan
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
